eVTOL traded as three separate stories on 2026-07-01: Joby Aviation closed at $8.92 on 56,236,465 shares, Archer Aviation closed at $4.73 on 30,261,249 shares, and EHang closed at $6.55 on 1,201,126 shares. The common theme was not just price direction but which company had earned the right to be treated as an execution story rather than a concept stock. Macro still framed the tape, with the U.S. 10-year Treasury yield at 4.42% and Fed Funds at 3.63%, which remains a restrictive backdrop for long-duration eVTOL valuations.
For today’s detailed market data, see Joby Daily, Archer Daily, and EHang Daily.
Does Toyota’s unfinished second tranche say more about Joby’s execution gate than its financing risk?
My read: the strongest signal in Joby’s session was not the stock pop by itself but the market’s decision to treat Toyota’s updated ownership disclosure as evidence of commitment rather than hesitation. Toyota still held 128,454,401 Joby shares, equal to 13.1% of the company, and the amended disclosure described a manufacturing joint venture in which Toyota owns 51% and can designate a board majority. Those are not the terms of a strategic partner stepping back from the table. They are the terms of a partner that has already committed meaningful capital and influence, then tied the next check to measurable execution. The relevant source set points in the same direction: Toyota’s official manufacturing-alliance release emphasized industrial cooperation, while the amended 13D summary made clear that the current agreement alone does not satisfy the closing conditions for the second tranche investment. The two documents work together as a message that scale support exists, but milestone discipline still governs the next stage.
That distinction matters because JOBY’s market data does not read like a company facing an urgent funding scare. The stock closed at $8.92, up 3.36%, on 56,236,465 shares, by far the heaviest volume among the three public names followed in this series. Yet the chart also shows why investors did not fully re-rate the company in one session: JOBY remained below its 20-day moving average of 9.63, even though it essentially matched its 5-day average of 8.91, and RSI14 at 45.92 stayed neutral rather than overbought. The way I see it, that is classic “proof still required” behavior. Investors rewarded the industrial story, but they did not declare the execution debate finished. In a high-rate market where the 10-year yield is still 4.42%, future production claims earn less valuation credit unless they are backed by visible milestones.
The next trigger, then, is probably not another broad partnership headline. It is the first hard sign that Toyota’s manufacturing role is compressing Joby’s path from narrative to output: clearer production-ramp detail, a certification milestone that changes how investors underwrite timing, or tape strength strong enough to reclaim the 20-day average and hold it. I think the directional lean here is constructive, because Toyota’s existing stake and governance position reduce the odds that this is a superficial endorsement. But it is a disciplined constructive view, not a blind one. Until the second tranche conditions visibly move closer to satisfaction, the market is likely to treat Joby as the sector’s best industrial story in progress rather than as a fully validated scale winner. Sources: Toyota manufacturing alliance release; Toyota amended 13D summary.
Is Archer being priced as a partner-rich company that still has not converted narrative into production confidence?
Archer’s session looked like the market drawing a line between ecosystem quality and execution quality. The company still has headline support that most emerging aerospace programs would want: the circulated coverage reiterated a roughly $6 billion backlog and highlighted commercial or strategic ties with United, Abu Dhabi Aviation, Anduril, and Stellantis. On paper, that is enough to keep the long-term commercialization thesis alive. In the tape, though, ACHR only closed at $4.73, up 1.07%, even with 30,261,249 shares traded. That is active participation without strong conviction. The technical setup reinforces the caution: the stock remained below its 5-day moving average of 4.82 and its 20-day moving average of 5.42, while RSI14 at 39.11 signaled weakness without a capitulation washout. Compared with Joby’s stronger relative response, Archer looked like a company still asking the market to believe ahead of proof.
The governance item from the 2026 annual meeting added to that mood. Directors Barbara Pilarski and Maria Pinelli were elected, but the Delaware-to-Texas redomestication proposal failed to receive the required shareholder approval. That outcome does not directly change aircraft output, certification timing, or revenue generation, so it would be overstated to call it a fundamental break. Still, it does remind investors that Archer’s 2026 news flow is not yet dominated by industrial conversion milestones. My view is that the market has become selective about what kind of “progress” deserves a valuation response. In a restrictive rate environment, broad partner lists and backlog figures matter less if investors cannot connect them to manufacturing cadence, certification clarity, or revenue timing. The company’s backlog can remain real and strategically important while its equity still trades at a discount to those future dollars.
The directional lean here is cautious. I do not read today’s action as a collapse of the Archer thesis, because the partner base and backlog still provide a credible commercial frame. But I do read it as evidence that the market wants an operating bridge from story to delivery. A substantive certification update, a production milestone with concrete numbers, or evidence that the manufacturing relationship with Stellantis is translating into repeatable output would likely matter more than another comparative commentary piece. Until that happens, Archer may continue to trade as the company with enough allies to stay relevant but not enough fresh proof to command premium confidence. Sources: AOL-syndicated Archer commentary; Archer annual meeting 8-K summary; ARKX holdings page.
Was EHang’s rise a genuine rerating signal, or mostly a low-volume echo of Joby-led sector attention?
EHang’s move deserves attention, but mostly because it shows how thinly traded strength can be misread in a thematic sector. EH closed at $6.55, up 3.48%, which superficially looked stronger than Archer and nearly matched Joby’s percentage gain. The volume context changes the interpretation immediately: EH traded only 1,201,126 shares, versus 56,236,465 for JOBY and 30,261,249 for ACHR. That is an enormous information gap. A 3.48% move on 1.2 million shares can reflect sympathy buying, short-covering, or light-risk appetite rather than a broad institutional decision to re-rate the company. The source bundle reviewed for this run did not contain a fresh EHang-specific catalyst, and the official EHang channels did not surface a new in-window release. When price rises without a verified company-specific driver, the cleanest interpretation is usually the simplest one: the stock benefited from sector flow more than from company news.
The chart reads the same way. EH finished above its 5-day moving average of 6.39, which is a constructive short-term detail, but it remained below its 20-day moving average of 7.34, and RSI14 at 48.12 stayed neutral rather than breakout-like. That is stabilization, not leadership. I think this matters even more when compared with Joby’s session, because Joby had the day’s clearest industrial catalyst in Toyota and still did not fully clear its own medium-term technical barrier. If the strongest fundamental story in the group is still working through resistance, then a thinner name with no fresh catalyst should be judged even more carefully. The macro backdrop adds another reason for restraint: with Fed Funds at 3.63% and the 10-year yield at 4.42%, long-duration growth names still need company-specific proof to escape being treated as tactical trades.
The directional lean here is neutral to slightly skeptical. EHang did not do anything wrong today; it simply did not produce enough verified evidence to justify calling the move a new rerating. For that to change, the company likely needs its own commercialization, regulatory, or operating milestone that can pull capital on its own rather than in the wake of a better-funded U.S. peer. Until then, EH looks tradable but secondary: a stock that can rise with sector appetite, yet still lacks the day’s decisive evidence. Sources: EHang newsroom; EHang Daily; Toyota manufacturing alliance release.
What to Watch Tomorrow
First, watch whether JOBY can hold above its 5-day moving average of 8.91 while testing the 20-day moving average at 9.63, because that would show whether Toyota’s alliance is becoming sustained execution confidence rather than a one-day reaction.
Second, watch whether Archer produces a certification or production datapoint that is stronger than governance maintenance, because that is the clearest trigger that could narrow the current credibility gap with Joby.
Third, watch whether EHang can extend gains on meaningfully higher volume than 1,201,126 shares, because continuation without broader participation would still look more like sympathy trading than a company-specific rerating.
This is not financial advice. Do your own research.
Follow @futurewatchlog for daily eVTOL coverage.
Previous insight: https://futurewatchlog.com/2026/06/30/evtol-daily-insight-2026-06-30/